Sartorius Stedim Biotech
€208.20Change from previous close: +0.97%Absolute change: +€2.00
At a glance
- Revenue growth
- +6.74%
- 2025 vs 2024
- Net income growth
- +51.68%
- 2025 vs 2024
- Net margin
- 9.0%
- 2024: 6.3%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total assets | 7,918 | 8,190 | 7,984 | 8,312 | 8,304 |
| Current assets | 1,353 | 1,651 | 1,441 | 1,807 | 1,780 |
| Cash and equivalents | 204 | 521 | 426 | 699 | 708 |
| Short-term investments | 28.9 | 26.2 | 8.1 | 45.8 | 19.4 |
| Inventory | 714 | 715 | 691 | 694 | 684 |
| Net property, plant and equipment | 2,064 | 2,034 | 2,025 | 1,954 | 1,927 |
| Goodwill | 2,894 | 2,888 | 2,884 | 2,889 | 2,901 |
| Other intangible assets | 1,500 | 1,515 | 1,537 | 1,569 | 1,599 |
| Long-term investments | 11.0 | — | 10.3 | — | — |
| Current liabilities | 1,166 | 1,609 | 1,412 | 946 | 965 |
| Accounts payable | 289 | 293 | 278 | 347 | 317 |
| Long-term debt | 1,942 | 1,861 | 1,867 | 2,684 | 2,684 |
| Total debt | 2,403 | 2,615 | 2,599 | 2,969 | 2,933 |
| Total liabilities | 3,671 | 4,047 | 3,858 | 4,273 | 4,296 |
| Total equity (incl. minority) | 4,247 | 4,143 | 4,126 | 4,039 | 4,008 |
| Retained earnings | 2,793 | 2,665 | 2,647 | 2,560 | 2,529 |
| Minority interest | 10.0 | 34.6 | 35.6 | 35.8 | 35.7 |